Graft versus Host Disease (GVHD) market- Epidemiology Forecast To 202 Graft versus Host Disease Market (GVHD) | Page 3

Graft versus Host Disease (GVHD) - Market
Insights, Epidemiology and Market Forecast-
2023- United States
• The incident rate of GVHD in unrelated donor (URD) is much higher in comparison to the sibling donors
(SD), irrespective of the sub-types i.e., acute GVHD (aGVHD) or chronic GVHD (cGVHD). As per forecasts,
the diagnosed incidence cases of aGVHD in sibling donors and aGVHD in unrelated donors, shall increase
at a CAGR of 1.00% and 4.14%, respectively, from 2013-2023. In case of cGVHD, the number of
diagnosed incident population cGVHD in sibling donors and cGVHD in unrelated donors is expected to
accentuate at a CAGR of 1.00% and 4.14%, respectively, by the end of the year 2023.
• The market size of GVHD mainly comprises of the off-label biologics. Many companies are working on
the development of targeted therapy and in the near future, these drugs may create an impact on the
overall market size of GVHD. ’estimates suggest that the forecasted market size of Graft Versus Host
Disease (GVHD) in United States shall increase at a CAGR of 4.62% from 2013 to 2023.
• The report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house Forecast model analysis by Publisher team of industry experts.
Inquire more before buying this report at
http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=824359